CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Neural Therapeutics Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Neural Therapeutics Inc
77 King Street West, Suite 2905
Phone: (226) 218-2255p:226 218-2255 TORONTO, ON  M5K 1H1  Canada Ticker: NURLNURL
Business Summary
Neural Therapeutics Inc. is a Canada-based ethnobotanical drug discovery company. The Company is focused on the development of therapeutic drugs for mental illnesses related to substance use disorders, including alcohol and opioid dependence. It is conducting research with psychoactive plants, the first being a cactus commonly known as San Pedro (Echinopsis pachanoi) containing mescaline. The Company’s approach to drug development involves the strategic use of sub-hallucinogenic doses of mescaline extract, enhancing safety and scalability while maintaining therapeutic efficacy.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
1/31/20257/31/2024-----

Industries
SIC Code Description
8731 Commercial physical and biological research

General Information
Outstanding Shares: 88,700,524 (As of 3/17/2025)
Stock Exchange: CNQ


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, June 27, 2025